|
NOVEMBER / DECEMBER
2004
FEATURES
Acibadem targets breast cancer with latest education
program
 |
| Dr. Lowell E. Schnipper |
Acibadem Healthcare Group, behind an ambitious plan to
become the focal point of progress for health care in Turkey, has teamed
with HMI to develop a series of multidisciplinary education programs for
physicians and nurses in the Acibadem network. October is international
Breast Cancer Awareness Month, and Acibadem marked the occasion with a two-day
oncology program led by Dr. Lowell Schnipper.
Since the HMI-Acibadem partnership was initiatied a little over a year ago,
HMI has been working with Acibadem to optimize the concept designs of planned
facilites, in addition to developing education programs for physicians and
nurses and supporting quality improvement efforts. Acibadem has recently opened
Kozyatagi Hospital, a center of excellence for oncology and neuroscience. The
leadership of Acibadem sees the continual infusion of new knowledge and research
as an integral piece in the development of Kozyatagi Hospital into a top resource
for oncology care. The overarching objectives of the oncology program were
to reinforce the concept of team-oriented care for cancer patients, and to
discuss how Acibadem can establish a multidisciplinary cancer clinic that leverages
the expertise of medical oncologists, surgeons, nurses, social workers, radiologists,
radiation oncologists, and pharmacists to not only provide the best medical
care, but also to address psychosocial and educational needs of patients and
families.
“ I am very pleased with what has been accomplished. We worked with our
own clinical staff, had visitors from the medical community who attended the
conference, and had a very emotional meeting with lay people from the community,
most of them cancer patients,” said Prof. Dr. Metin Cakmakci, medical director
of Acibadem.
Schnipper, the Theodore and Evelyn Berenson professor
of medicine at Harvard Medical School, worked with HMI and the clinical
leadership at Acibadem to design a program addressing the continuum of cancer
care, with a full day dedicated to breast cancer. In addition to discussions
of the biology of cancer—and approaches to managing and treating it—the
program focused on building a team-oriented approach to providing compassionate,
comprehensive care for oncology patients.
Commitment to enhancing care
" We are currently witnessing a knowledge explosion in the field of oncology,
with new information about the biology of cancer emerging in laboratories around
the world,” said Schnipper, who leads the oncology division at Beth Israel
Deaconess Medical Center (BIDMC) in Boston. “I am impressed and inspired
by the vigor with which HMI’s partners in Turkey are working to enhance
the care of breast cancer patients. Acibadem is now poised to develop a multi-disciplinary
breast cancer program which could serve as the prototype for other programs to
be developed there.”
Cakmakci added, “Acibadem Healthcare Group is committed to the idea of
multidisciplinary health clinics and centers and is determined to realize this
approach in every appropriate area of medicine and applicable disease—but
especially in cancer clinics.”
Acibadem’s breast cancer clinic is already beginning to provide care. “We
aim to be able to prospectively plan treatment for each patient and achieve
synergy among our different units and professionals, instead of providing care
independently as we have traditionally,” said Cakmakci. “Our ultimate
goal is to ensure that our patients do not feel lost in the complicated process
of getting care within the intricate health care delivery systems of today.
This two-day education program met our needs, enabled us to notice our missing
pieces, and inspired a lot of local solutions.”
Breast cancer is the most common cancer among women worldwide, and is on the
rise, according to the World Health Organization’s International Agency
for Research on Cancer. The number of women with breast cancer increased 26
percent from 1980 to 1985, and the organization estimated 1.2 million new cases
and 500,000 deaths from breast cancer worldwide in the year 2000.
The program was attended by representatives from the oncology, surgery, radiation
oncology, radiation, and nursing departments at Acibadem. In a series of lectures,
Schnipper traced cancer from its genesis in the cell through the numerous pathways
critical to its development, highlighting opportunities to inhibit critical
steps in the life cycle of the cancer cell, and exploring the current thinking
about the genetic predisposition to breast cancer. He discussed the basic concepts
that form the foundation of contemporary breast cancer therapy, including considerations
for both local and systemic treatment, new hormonal agents that have been introduced
into the clinic, and the promise held by targeted therapy.
“One of my objectives in these lectures was to make clear the basis for
optimism about major progress against cancer within the next five to ten years, ” said
Schnipper.
 |
| From left to right: Hester Hill Schnipper, LICSW,
BCD; Chris Richards, RN, MSN; and Saliha Koc, RN, Director of Nursing
at Acibadem. |
Introducing a team-oriented
approach to care
The program went beyond the laboratory to explore approaches being employed
in clinics, where nurses and social workers play a key role in helping patients
and their families cope with cancer. Chris Richards, RN, MSN, is the clinical
nurse specialist for BIDMC’s hematology/oncology outpatient department.
She talked about the nurse’s multifaceted role in the care of breast
cancer patients, not only in surgery and radiation, but also as it relates
to pre-operative education, post-operative care and potential complications,
and helping patients who are receiving radiotherapy.
“The concept of multidisciplinary care centers around the provision of
a comprehensive, individualized plan of care for the patient facing breast cancer.
This plan addresses the needs of the patient from a holistic perspective and
requires input from different members of the health care team,” said Richards. “Acibadem
has all of the resources that make up a multidisciplinary cancer care team, but
they have been working independently. Now it’s just a matter of pulling
them together to work as a group. I was impressed with the eagerness and willingness
on the part of everyone I met at Acibadem to embrace this concept and carry it
forward.” Richards added that while Acibadem is at the cutting edge of
technology, the notion of patient advocacy as part of the care provider’s
role is new.
Hester Hill Schnipper, LICSW, BCD is the chief of oncology social work at BIDMC.
She has worked in the field of psychosocial oncology for more than twenty-five
years, and her insight into the care of breast cancer patients is informed
not only by her experience as a clinician, but by her own treatment for breast
cancer. She led a workshop at Acibadem on how to establish a working system
of oncology social work and a minimally guided patient support network. Support
and communication are critical for patients both before and after treatment. “Oncology
social workers facilitate patients’ adjustment to a diagnosis and treatment
of cancer and, working with the family and the interdisciplinary medical team,
work towards optimal coping and functioning through the cancer experience,” she
said.
During the workshop, Hill Schnipper discussed the value of individual counseling,
support groups, patient/peer support networks, and other ways of fostering
community among oncology patients. Currently, the role of oncology social worker
does not exist in Turkey, but Hill Schnipper and the clinical leadership at
Acibadem believe that psychologists and nurses on staff at the hospital may
be able to take the lead in developing and leading patient/peer support groups.
The program closed with an emotional discussion between the HMI faculty and
members of the Istanbul community, many of whom were cancer patients. The HMI
faculty fielded a wide range of questions from the audience. “I was quite
moved by the openness of the people who shared their life experiences with
us and sought counsel,” said Richards.
More education programs are on the way for Acibadem’s physicians and
nurses. In November, Dr. Galen Henderson of Brigham and Women’s Hospital
will lead a workshop with Mary Amatangelo, NP and Dr. Andrew Cole on the management
of cerebrovascular disease and epilepsy.
-
Copyright 2004-2005 Harvard Medical
International http://hmiworld.org/
|